LENZ Therapeutics Inc (LENZ) Stock Analysis

LENZ Therapeutics Inc (LENZ) is a publicly traded company in the HEALTHCARE sector. It trades at $7.13, carries a market capitalization of $233.28M. This page summarizes the public market data, fundamentals, and frequently asked questions for LENZ, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.13
• Market Cap: $233.28M
• EPS: $-3.64
• 52-Week High: $50.40
• 52-Week Low: $6.61

Market Sentiment

LENZ Therapeutics Inc currently has a Bullish sentiment score of 0.38.

About LENZ Therapeutics Inc

None

GNG Research Analysis

GNG Research scores LENZ Therapeutics Inc (LENZ) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LENZ.

Frequently Asked Questions

Does LENZ pay dividends?

LENZ Therapeutics Inc (LENZ) does not currently pay a regular dividend.

What is LENZ's market cap?

LENZ Therapeutics Inc (LENZ) has a market capitalization of $233.28M with a current stock price of $7.13.